Atlas Trials

Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H

Clinical trial NCT02627118 · COMPLETED

Trial details

NCT number
NCT02627118
Sponsor
UConn Health
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
End Stage Renal Disease
Start date
2015-04-01
Primary completion
2016-07-11
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.